1. Home
  2. CASI vs CYN Comparison

CASI vs CYN Comparison

Compare CASI & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • CYN
  • Stock Information
  • Founded
  • CASI 1991
  • CYN 2013
  • Country
  • CASI China
  • CYN United States
  • Employees
  • CASI N/A
  • CYN N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • CYN EDP Services
  • Sector
  • CASI Health Care
  • CYN Technology
  • Exchange
  • CASI Nasdaq
  • CYN Nasdaq
  • Market Cap
  • CASI 35.8M
  • CYN 42.0M
  • IPO Year
  • CASI 1996
  • CYN 2021
  • Fundamental
  • Price
  • CASI $1.84
  • CYN $6.09
  • Analyst Decision
  • CASI Strong Buy
  • CYN
  • Analyst Count
  • CASI 1
  • CYN 0
  • Target Price
  • CASI $4.00
  • CYN N/A
  • AVG Volume (30 Days)
  • CASI 305.0K
  • CYN 286.3K
  • Earning Date
  • CASI 11-13-2025
  • CYN 11-05-2025
  • Dividend Yield
  • CASI N/A
  • CYN N/A
  • EPS Growth
  • CASI N/A
  • CYN N/A
  • EPS
  • CASI N/A
  • CYN N/A
  • Revenue
  • CASI $31,564,000.00
  • CYN $434,837.00
  • Revenue This Year
  • CASI N/A
  • CYN $31.96
  • Revenue Next Year
  • CASI N/A
  • CYN $1,459.25
  • P/E Ratio
  • CASI N/A
  • CYN N/A
  • Revenue Growth
  • CASI 36.64
  • CYN 445.29
  • 52 Week Low
  • CASI $1.09
  • CYN $3.62
  • 52 Week High
  • CASI $7.50
  • CYN $1,312.50
  • Technical
  • Relative Strength Index (RSI)
  • CASI 51.04
  • CYN 52.28
  • Support Level
  • CASI $1.77
  • CYN $5.51
  • Resistance Level
  • CASI $2.08
  • CYN $6.82
  • Average True Range (ATR)
  • CASI 0.20
  • CYN 0.43
  • MACD
  • CASI 0.02
  • CYN 0.11
  • Stochastic Oscillator
  • CASI 71.84
  • CYN 45.80

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: